Quantitative analysis for Equillium, Inc. (EQ) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (63.0) (grade B). 27 signals analyzed (23 differentiated alt-data).
EQ stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $2.22 | $2.01 | $2.05 |
| 2026-05-08 | $2.27 | $2.10 | $2.11 |
| 2026-05-20 | $2.09 | $1.78 | $2.06 |
| 2026-06-02 | $2.99 | $2.23 | $2.79 |
| 2026-06-12 | $2.96 | $2.71 | $2.81 |
| 2026-06-25 | $3.05 | $2.86 | $2.95 |
| 2026-07-08 | $3.16 | $2.79 | $3.15 |
| 2026-07-20 | $2.63 | $2.45 | $2.47 |
| 2026-07-30 | $2.39 | $2.22 | $2.32 |
| 2026-08-12 | $2.28 | $2.14 | $2.18 |
| 2026-08-24 | $2.31 | $2.17 | $2.20 |
| 2026-09-03 | $2.31 | $2.18 | $2.22 |
How Equillium, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ACET | Adicet Bio, Inc. | $73M | — |
| QTTB | Q32 Bio Inc. | $72M | — |
| HYFT | MindWalk Holdings Corp. | $74M | — |
| PLRX | Pliant Therapeutics, Inc. | $74M | — |
View all Health Care stocks by valuation and signals →
Equillium, Inc. (EQ) scores Buy (63.0), with no measured dimension below 69. Its highest are competitive moat at 93, technicals at 72, analyst consensus at 69, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 93 |
| technicals | 72 |
| analyst consensus | 69 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Equillium, Inc. (EQ): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/EQ"><img src="https://stoquant.com/badge/EQ.svg" alt="Equillium, Inc. (EQ) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.